This IL1–IL6 cycle intensifies systemic inflammation (e.g., increasing C-reactive protein) and shapes a tumor-promoting environment by recruiting immune-suppressive cells and fostering angiogenesis, aiding tumor survival and immune evasion [208]. The gene discussed is IL1B; the disease is neoplasm.